2,6-Diaminopyridine Compounds Suitable For Treating Diseases Associated With Amyloid Or Amyloid-Like Proteins Or For Treating Or Preventing Ocular Diseases Or Conditions Associated With A Pathological Abnormality/Change In The Tissue Of The Visual System
[EN] 2, 6 -DIAMINOPYRIDINE COMPOUNDS FOR TREATING DISEASES ASSOCIATED WITH AMYLOID PROTEINS OR FOR TREATING OCULAR DISEASES [FR] COMPOSÉS 2,6 DIAMINOPYRIDINES APPROPRIÉS POUR LE TRAITEMENT DE MALADIES ASSOCIÉES AUX PROTÉINES AMYLOÏDES OU DE TYPE AMYLOÏDE POUR LE TRAITEMENT OU LA PRÉVENTION DE MALADIES OU D'ÉTATS OCULAIRES ASSOCIÉS À UNE ANOMALIE/CHANGEMENT PATHOLOGIQUE DANS LE
Cyclization of 2-Aminopyridine Derivatives. III. Reaction of Some 2-Aminopyridines with Alkyl Acrylates and Alkyl 3-Halopropionates
作者:GERALD R. LAPPIN
DOI:10.1021/jo01103a034
日期:1958.9
CARBONI S.; SETTIMO A. DA; BERTINI D.; FERRARINI P. L.; LIVI O.; TONETTI +, FARMACO. ED. SCI. <FSTE-AI>, 1975, 30, NO 4, 237-247
作者:CARBONI S.、 SETTIMO A. DA、 BERTINI D.、 FERRARINI P. L.、 LIVI O.、 TONETTI +
DOI:——
日期:——
2,6-Diaminopyridine Compounds Suitable For Treating Diseases Associated With Amyloid Or Amyloid-Like Proteins Or For Treating Or Preventing Ocular Diseases Or Conditions Associated With A Pathological Abnormality/Change In The Tissue Of The Visual System
申请人:Kroth Heiko
公开号:US20110092537A1
公开(公告)日:2011-04-21
The present invention relates to 2,6-diaminopyridine compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system.
[EN] 2, 6 -DIAMINOPYRIDINE COMPOUNDS FOR TREATING DISEASES ASSOCIATED WITH AMYLOID PROTEINS OR FOR TREATING OCULAR DISEASES<br/>[FR] COMPOSÉS 2,6 DIAMINOPYRIDINES APPROPRIÉS POUR LE TRAITEMENT DE MALADIES ASSOCIÉES AUX PROTÉINES AMYLOÏDES OU DE TYPE AMYLOÏDE POUR LE TRAITEMENT OU LA PRÉVENTION DE MALADIES OU D'ÉTATS OCULAIRES ASSOCIÉS À UNE ANOMALIE/CHANGEMENT PATHOLOGIQUE DANS LE